PLANTS FOR PRODUCTION OF THERAPEUTIC PROTEINS

Abstract

Materials and Methods are provided for making plants (e.g., Nicotiana varieties) that are suitable for producing therapeutic polypeptides suitable for administration to humans and animals, particularly by making TAL effector endonuclease-induced mutations in genes encoding xylosyltransferases and fucosyltransferases.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims benefit of priority from U.S. Provisional Application Ser. No. 61/790,850, filed on Mar. 15, 2013, and U.S. Provisional Application Ser. No. 61/721,194, filed on Nov. 1, 2012.

TECHNICAL FIELD

This document relates to materials and methods for making plants that are suitable for production of therapeutic proteins for administration to humans and animals, particularly by making targeted knockouts in genes encoding xylosyltransferases and fucosyltransferases. This document also relates to Nicotiana varieties that lack xylosyltransferase and fucosyltransferase activity.

BACKGROUND

Unlike animal glycoproteins, plant glycoproteins have beta(1,2)xylosyl and core-alpha(1,3) fucosyl residues, and lack terminal beta(1,4) galactosyl residues and sialic acid. Beta-1,2-xylosyltransferase (“XylT”) catalyzes the transfer of xylose from UDP-xylose to the core β-linked mannose of protein-bound N-glycans. This enzyme is unique to plants and some non-vertebrate animal species, and does not occur in human beings or in other vertebrates. α-1,3-fucosyltransferase (“FucT”) catalyzes the transfer of fucose from GDP-fucose to the core β-linked N-acetyl glucosamine (GlcNAc) of protein-bound N-glycans. This enzyme is found in plant and animal species, including humans.

SUMMARY

This document provides materials and methods for making plants that are particularly useful for production of therapeutic proteins suitable for administration to humans and animals, particularly by making targeted knockouts in genes encoding xylosyltransferases and fucosyltransferases. This document also provides Nicotiana varieties that lack xylosyltransferase and fucosyltransferase activity.

This disclosure is based at least in part on the discovery that plants suitable for producing proteins for administration to humans and animals can be made by knocking out all copies of the genes encoding xylosyl- and fucosyltransferases. This disclosure also is based at least in part on the development of N. benthamiana varieties that lack xylosyl- and fucosyltransferase activities. Having the ability to make viable plants that lack xylosyl- and fucosyltransferase activities can facilitate production of therapeutic proteins for administration to humans and animals, with a lower incidence of immunogenic or allergic reactions as compared to proteins produced in plants with xylosyl- and fucosyltransferase activity.

In one aspect, this document features a Nicotiana plant or plant cell having a transcription activator-like (TAL) effector endonuclease-induced mutation in each XylT and FucT allele endogenous to the plant or plant cell. The plant or plant cell does not produce detectable levels of beta-1,2-xylosyl- or core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in the plant or plant cell. The TAL effector endonuclease-induced mutation can be at one or more target sequences as set forth in SEQ ID NOS:1, 2, or 3. The TAL effector endonuclease-induced mutation can be induced by a TAL effector endonuclease that binds to a sequence as set forth in any of SEQ ID NOS:45-63. The plant or plant cell can contain a nucleic acid encoding a heterologous polypeptide.

In another aspect, this document features a method for producing a polypeptide. The method can include: (a) providing a Nicotiana plant or plant cell having a TAL effector endonuclease-induced mutation in each XylT and FucT allele endogenous to the plant, wherein the plant or plant cell does not produce detectable levels of beta-1,2-xylosyl- and core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in the plant or plant cell, and wherein the plant or plant cell contains a nucleic acid comprising (i) a nucleotide sequence encoding a polypeptide operably linked to (ii) a plant-expressible promoter and (iii) a sequence involved in transcription termination and polyadenylation, wherein the polypeptide is heterologous to said plant; and (b) maintaining the plant or plant cell under conditions and for a time sufficient that the heterologous polypeptide is produced. In some cases, the method can include isolating the heterologous polypeptide from the plant or plant cell.

In another aspect, this document features a Nicotiana plant or plant cell having a mutation in each of a plurality of XylT alleles and a mutation in each of a plurality of FucT alleles, wherein the plant or plant cell does not produce detectable levels of beta-1,2-xylosyl- or core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in the plant or plant cell. The mutations can be at one or more sequences as set forth in SEQ ID NOS:1, 2, or 3. The mutations can have been induced by one or more rare-cutting endonucleases (e.g., one or more TAL effector endonucleases). Each of the TAL effector endonucleases can bind to a sequence as set forth in any of SEQ ID NOS:45-63. The plant or plant cell can contain a nucleic acid encoding a heterologous polypeptide. Each mutation can be a deletion of more than one nucleotide. Each of the plurality of XylT alleles and the plurality of FucT alleles can have a deletion of an endogenous nucleic acid sequence, without including any exogenous nucleic acid. The plant or plant cell can be a N. benthamiana plant or plant cell.

In another aspect, this document features a method for producing a polypeptide. The method can include (a) providing a Nicotiana plant or plant cell having a mutation in each of a plurality of XylT alleles and a mutation in each of a plurality of FucT alleles, wherein the plant or plant cell does not produce detectable levels of beta-1,2-xylosyl- and core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in the plant or plant cell, and wherein the plant or plant cell contains a nucleic acid comprising (i) a nucleotide sequence encoding a polypeptide operably linked to (ii) a plant-expressible promoter and (iii) a sequence involved in transcription termination and polyadenylation, wherein the polypeptide is heterologous to the plant; and (b) growing the plant or plant cell under conditions and for a time sufficient that the heterologous polypeptide is produced. The method can further include isolating the heterologous polypeptide from the plant or plant cell. The mutations can be induced by one or more rare-cutting endonucleases (e.g., one or more TAL effector endonucleases). Each of the TAL effector endonucleases can bind to a sequence as set forth in any of SEQ ID NOS:45-63.

In still another aspect, this document features a method for making a Nicotiana plant having a mutation in each of a plurality of XylT alleles and a mutation in each of a plurality of FucT alleles. The method can include (a) contacting a population of Nicotiana plant cells containing functional XylT alleles and functional FucT alleles with one or more rare-cutting endonucleases targeted to endogenous XylT sequences, and one or more rare-cutting endonucleases targeted to endogenous FucT sequences, (b) selecting, from the population, a cell in which a plurality of XylT alleles and a plurality of FucT alleles have been inactivated, and (c) regenerating the selected plant cell into a Nicotiana plant, wherein the Nicotiana plant comprises mutations in a plurality of XylT alleles and mutations in a plurality of FucT alleles, and does not produce detectable levels of beta-1,2-xylosyl- or core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in the plant. The Nicotiana plant cells can be protoplasts. The method can include transforming the protoplasts with one or more vectors comprising encoding a rare-cutting endonuclease. The rare-cutting endonuclease can be a TAL effector endonuclease. Each of the TAL effector endonucleases can be targeted to a sequence as set forth in any of SEQ ID NOS:45-63. The method can include introducing into the protoplasts a TAL effector endonuclease protein. The method can further include culturing the protoplasts to generate plant lines. The method can include comprising isolating genomic DNA containing at least a portion of a XylT locus or at least a portion of a FucT locus from the protoplasts. The Nicotiana plant cells can be N. benthamiana plant cells.

This document also features a method for generating a Nicotiana plant comprising a mutation in each of a plurality of XylT alleles and a mutation in each of a plurality of FucT alleles. The method can include (a) crossing a first Nicotiana plant having a mutation in at least one XylT allele and a mutation in at least one FucT allele with a second Nicotiana plant having a mutation in at least one XylT allele and a mutation in at least one FucT allele, to obtain progeny; and (b) selecting from the progeny a Nicotiana plant that comprises mutations in a plurality of XylT alleles and mutations in a plurality of FucT alleles. The mutations can be induced by one or more rare-cutting endonucleases (e.g., one or more TAL effector endonucleases). Each of the TAL effector endonucleases can bind to a sequence as set forth in any of SEQ ID NOS:45-63. Each of the mutations can be a deletion of more than one nucleotide. The progeny can be homozygous for the mutations at each of the alleles.

Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although methods and materials similar or equivalent to those described herein can be used to practice the invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.

The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.

DESCRIPTION OF DRAWINGS

FIG. 1 shows target sites for XylT TAL effector endonucleases. The DNA sequence for both of the XylT genes is shown (SEQ ID NO:1; the DNA sequences for the two XylT genes are the same in this region), beginning with the start codon (ATG). The underlined sequences represent target sites the TAL effector endonucleases that recognize the XylT genes.

FIG. 2 shows target sites for FucT TAL effector endonucleases. The DNA sequences for the two FucT genes (FucT1, SEQ ID NO:2; FucT2, SEQ ID NO:3) are shown, beginning with the start codon (ATG). The underlined sequences represent target sites for TAL effector endonucleases that recognize the FucT genes. Sequence differences between FucT1 and FucT2 are indicated in bold type.

FIG. 3 shows examples of TAL effector endonuclease-induced mutations in the XylT genes. The top line of each panel shows the DNA sequence of the recognition site for the XylT_T04 TAL effector endonucleases (underlined and in capital letters) in either the XylT1 (top panel) or XylT2 (bottom panel) gene. The other sequences show representative mutations that were induced by imprecise non-homologous end joining (NHEJ), with the sizes of deletions given on the right.

FIG. 4 shows examples of TAL effector endonuclease-induced mutations in the FucT genes. The top line of each panel shows the DNA sequence of the recognition site for the FucT_T02 TAL effector endonucleases (underlined and in capital letters) in either the FucT1 (top panel) or FucT2 (bottom panel) gene. The other sequences show representative mutations that were induced by imprecise NHEJ, with the sizes of deletions given on the right.

DETAILED DESCRIPTION

This document provides plants of the genus Nicotiana that lack xylosyltransferase and fucosyltransferase activity, as well methods for generating such plants, and methods for using such plants for producing polypeptides suitable for administration to humans and animals. Members of the Nicotiana genus include, for example, the species benthamiana, tabacum, sylvestris, acaulis, acuminate, africana, alata, ameghinoi, amplexicaulis, arentsii, attenuate, azambujae, benavidesii, bonariensis, burbidgeae, cavicola, clevelandii, cordifolia, corymbosa, cutleri, debneyi, excelsior, exigua, forgetiana, fragrans, glauca, glutinosa, goodspeedii, gossei, hesperis, heterantha, ingulba, kawakamii, knightiana, langsdorffii, linearis, longibracteata, longiflora, maritime, megalosiphon, miersii, mutabilis, nesophila, noctiflora, nudicaulis, occidentalis, obtusifolia, otophora, paa, palmeri, paniculata, pauciflora, petuniodes, plumbaginifolia, quadrivalvis, raimondii, repanda, rosulata, rotundifolia, rustica, setchellii, simulans, solanifolia, spegazzinii, stenocarpa, stocktonii, suaveolens, thrysiflora, tomentosa, tomentosiformis, truncata, umbratica, undulate, velutina, wigandioides, and wuttkei.

In N. benthamiana, there are at least two members (XylT1 and XylT2) in the xylosyltransferase (XylT) gene family and at least two members (FucT1 and FucT2) in the fucosyltransferase (FucT) gene family. Representative examples of naturally occurring Nicotiana XylT and FucT nucleotide sequences are shown in Table 4. The Nicotiana plants, cells, plant parts, seeds, and progeny thereof provided herein have a mutation in each of a plurality of the endogenous XylT and FucT alleles, such that expression of each gene is reduced or completely inhibited. The plants, cells, parts, seeds, and progeny do not exhibit detectable levels of beta-1,2-xylosyl- or core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced therein.

The plants, plant cells, plant parts, seeds, and plant progeny provided herein can be generated using a rare-cutting endonuclease, such as a TAL effector endonuclease system, to make targeted knockouts in the XylT and FucT genes. Thus, this disclosure provides materials and methods for using TAL effector endonucleases to generate plants and related products (e.g., seeds and plant parts) that are particularly suitable for production of human and animal therapeutic proteins due to targeted knockouts in all alleles of the XylT and FucT genes. Other rare-cutting, sequence-specific nucleases to be used to generate the desired plant material, including engineered homing endonucleases or zinc finger nucleases.

“Plants” and “plant parts” refers to cells, tissues, organs, seeds, and severed parts (e.g., roots, leaves, and flowers) that retain the distinguishing characteristics of the parent plant. “Seed” refers to any plant structure that is formed by continued differentiation of the ovule of the plant, following its normal maturation point at flower opening, irrespective of whether it is formed in the presence or absence of fertilization and irrespective of whether or not the seed structure is fertile or infertile.

The term “allele(s)” means any of one or more alternative forms of a gene at a particular locus. In a diploid (or amphidiploid) cell of an organism, alleles of a given gene are located at a specific location or locus on a chromosome. One allele is present on each chromosome of the pair of homologous chromosomes. “Heterozygous” alleles are two different alleles residing at a specific locus, positioned individually on corresponding pairs of homologous chromosomes. “Homozygous” alleles are two identical alleles residing at a specific locus, positioned individually on corresponding pairs of homologous chromosomes in the cell.

“Wild type” as used herein refers to a typical form of a plant or a gene as it most commonly occurs in nature. A “wild type XylT allele” is a naturally occurring XylT allele (e.g., as found within naturally occurring Nicotiana plants) that encodes a functional XylT protein, while a “mutant XylT allele” is a XylT allele that does not encode a functional XylT protein. Such a “mutant XylT allele” can include one or more mutations in its nucleic acid sequence, where the mutation(s) result in no detectable amount of functional XylT protein in the plant or plant cell in vivo. Similarly, a “wild type FucT allele” is a naturally occurring FucT allele that encodes a functional FucT protein, while a “mutant FucT allele” is a FucT allele that does not encode a functional FucT protein. Such a “mutant FucT allele” can include one or more mutations in its nucleic acid sequence, where the mutation(s) result in no detectable amount of functional FucT protein in the plant or plant cell in vivo.

The term “rare-cutting endonucleases” herein refer to natural or engineered proteins having endonuclease activity directed to nucleic acid sequences having a recognition sequence (target sequence) about 12-40 bp in length (e.g., 14-40 bp in length). Typical rare-cutting endonucleases cause cleavage inside their recognition site, leaving 4 nt staggered cut with 3′0H or 5′0H overhangs. These rare-cutting endonucleases may be meganucleases, such as wild type or variant proteins of homing endonucleases, more particularly belonging to the dodecapeptide family (LAGLIDADG (SEQ ID NO:79); see, WO 2004/067736) or may result from fusion proteins that associate a DNA binding domain and a catalytic domain with cleavage activity. TAL-effector endonucleases and zinc-finger-nucleases (ZFN) are examples of fusions of DNA binding domains with the catalytic domain of the endonuclease FokI. Customized TAL effector endonucleases are commercially available under the trade name TALEN™ (Cellectis, Paris, France). For a review of rare-cutting endonucleases, see Baker, Nature Methods 9:23-26, 2012.

“Mutagenesis” as used herein refers to processes in which mutations are introduced into a selected DNA sequence. In the methods described herein, for example, mutagenesis occurs via a double stranded DNA breaks made by TAL effector endonucleases targeted to selected DNA sequences in a plant cell. Such mutagenesis results in “TAL effector endonuclease-induced mutations” and reduced expression of the targeted gene. Following mutagenesis, plants can be regenerated from the treated cells using known techniques (e.g., planting seeds in accordance with conventional growing procedures, followed by self-pollination).

In some cases, a nucleic acid can have a nucleotide sequence with at least about 75 percent sequence identity to a representative XylT or FucT nucleotide sequence. For example, a nucleotide sequence can have at least 75, at least 80, at least 85, at least 90, at least 91, at least 92, at least 93, at least 94, at least 95, at least 96, at least 97, at least 98, or at least 99 percent sequence identity to a representative, naturally occurring XylT or FucT nucleotide sequence

The percent sequence identity between a particular nucleic acid or amino acid sequence and a sequence referenced by a particular sequence identification number is determined as follows. First, a nucleic acid or amino acid sequence is compared to the sequence set forth in a particular sequence identification number using the BLAST 2 Sequences (Bl2seq) program from the stand-alone version of BLASTZ containing BLASTN version 2.0.14 and BLASTP version 2.0.14. This stand-alone version of BLASTZ can be obtained online at fr.com/blast or at ncbi.nlm.nih.gov. Instructions explaining how to use the Bl2seq program can be found in the readme file accompanying BLASTZ. Bl2seq performs a comparison between two sequences using either the BLASTN or BLASTP algorithm. BLASTN is used to compare nucleic acid sequences, while BLASTP is used to compare amino acid sequences. To compare two nucleic acid sequences, the options are set as follows: -i is set to a file containing the first nucleic acid sequence to be compared (e.g., C:\seq1.txt); -j is set to a file containing the second nucleic acid sequence to be compared (e.g., C:\seq2.txt); -p is set to blastn; -o is set to any desired file name (e.g., C:\output.txt); -q is set to −1; -r is set to 2; and all other options are left at their default setting. For example, the following command can be used to generate an output file containing a comparison between two sequences: C:\Bl2seq -i c:\seq1.txt -j c:\seq2.txt -p blastn -o c:\output.txt -q -1-r 2. To compare two amino acid sequences, the options of Bl2seq are set as follows: -i is set to a file containing the first amino acid sequence to be compared (e.g., C:\seq1.txt); -j is set to a file containing the second amino acid sequence to be compared (e.g., C:\seq2.txt); -p is set to blastp; -o is set to any desired file name (e.g., C:\output.txt); and all other options are left at their default setting. For example, the following command can be used to generate an output file containing a comparison between two amino acid sequences: C:\Bl2seq c:\seq1.txt -j c:\seq2.txt -p blastp -o c:\output.txt. If the two compared sequences share homology, then the designated output file will present those regions of homology as aligned sequences. If the two compared sequences do not share homology, then the designated output file will not present aligned sequences.

Once aligned, the number of matches is determined by counting the number of positions where an identical nucleotide or amino acid residue is presented in both sequences. The percent sequence identity is determined by dividing the number of matches either by the length of the sequence set forth in the identified sequence (e.g., SEQ ID NO:1), or by an articulated length (e.g., 100 consecutive nucleotides or amino acid residues from a sequence set forth in an identified sequence), followed by multiplying the resulting value by 100. For example, a nucleic acid sequence that has 80 matches when aligned with the sequence set forth in SEQ ID NO:1 is 88.9 percent identical to the sequence set forth in SEQ ID NO:1 (i.e., 80÷90×100=88.9). It is noted that the percent sequence identity value is rounded to the nearest tenth. For example, 75.11, 75.12, 75.13, and 75.14 is rounded down to 75.1, while 75.15, 75.16, 75.17, 75.18, and 75.19 is rounded up to 75.2. It also is noted that the length value will always be an integer

Methods for selecting endogenous target sequences and generating TAL effector endonucleases targeted to such sequences can be performed as described elsewhere. See, for example, PCT Publication No. WO 2011/072246, which is incorporated herein by reference in its entirety. TAL effectors are found in plant pathogenic bacteria in the genus Xanthomonas. These proteins play important roles in disease, or trigger defense, by binding host DNA and activating effector-specific host genes (see, e.g., Gu et al., Nature 435:1122-1125, 2005; Yang et al., Proc. Natl. Acad. Sci. USA 103:10503-10508, 2006; Kay et al. Science 318:648-651, 2007; Sugio et al., Proc. Natl. Acad. Sci. USA 104:10720-10725, 2007; and Römer et al. Science 318:645-648, 2007). Specificity depends on an effector-variable number of imperfect, typically 34 amino acid repeats (Schornack et al., J. Plant Physiol. 163:256-272, 2006; and WO 2011/072246). Polymorphisms are present primarily at repeat positions 12 and 13, which are referred to herein as the repeat variable-diresidue (RVD).

The RVDs of TAL effectors correspond to the nucleotides in their target sites in a direct, linear fashion, one RVD to one nucleotide, with some degeneracy and no apparent context dependence. This mechanism for protein-DNA recognition enables target site prediction for new target specific TAL effectors, as well as target site selection and engineering of new TAL effectors with binding specificity for the selected sites.

TAL effector DNA binding domains can be fused to other sequences, such as endonuclease sequences, resulting in chimeric endonucleases targeted to specific, selected DNA sequences, and leading to subsequent cutting of the DNA at or near the targeted sequences. Such cuts (i.e., double-stranded breaks) in DNA can induce mutations into the wild type DNA sequence via NHEJ or homologous recombination, for example. In some cases, TAL effector endonucleases can be used to facilitate site directed mutagenesis in complex genomes, knocking out or otherwise altering gene function with great precision and high efficiency. As described in the Examples below, TAL effector endonucleases targeted to each of the N. benthamiana XylT and FucT alleles can be used to mutagenize the endogenous genes, resulting in plants without detectable expression of these genes. The fact that some endonucleases (e.g., FokI) function as dimers can be used to enhance the target specificity of the TAL effector endonuclease. For example, in some cases a pair of TAL effector endonuclease monomers targeted to different DNA sequences (e.g., the underlined target sequences shown in FIGS. 1 and 2) can be used. When the two TAL effector endonuclease recognition sites are in close proximity, as depicted in FIGS. 1 and 2, the inactive monomers can come together to create a functional enzyme that cleaves the DNA. By requiring DNA binding to activate the nuclease, a highly site-specific restriction enzyme can be created.

The term “expression” as used herein refers to the transcription of a particular nucleic acid sequence to produce sense or antisense mRNA, and/or the translation of a sense mRNA molecule to produce a polypeptide (e.g., a therapeutic protein), with or without subsequent post-translational events.

“Reducing the expression” of a gene or polypeptide in a plant or a plant cell includes inhibiting, interrupting, knocking-out, or knocking-down the gene or polypeptide, such that transcription of the gene and/or translation of the encoded polypeptide are reduced as compared to a corresponding wild type plant or plant cell. Expression levels can be measured using methods such as, for example, reverse transcription-polymerase chain reaction (RT-PCR), Northern blotting, dot-blot hybridization, in situ hybridization, nuclear run-on and/or nuclear run-off, RNase protection, or immunological and enzymatic methods such as ELISA, radioimmunoassay, and western blotting.

Methods for using TAL effector endonucleases to generate plants, plant cells, or plant parts having mutations in endogenous genes include, for example, those described in the Examples herein. For example, nucleic acids encoding TAL effector endonucleases targeted to selected XylT or FucT sequences (e.g., the XylT sequences shown in FIG. 1 or the FucT sequences shown in FIG. 2) can be transformed into plant cells (e.g., protoplasts), where they can be expressed. The cells subsequently can be analyzed to determine whether mutations have been introduced at the target site(s), through nucleic acid-based assays or protein-based assays to detect expression levels as described above, for example, or using nucleic acid-based assays (e.g., PCR and DNA sequencing, or PCR followed by a T7E1 assay; Mussolino et al., Nucleic Acids Res 39:9283-9293, 2011) to detect mutations at the genomic loci.

The mutagenized population, or a subsequent generation of that population, can be screened for a desired trait(s) (e.g., plants that lack xylosyl- and fucosyltransferase activities) that results from the mutations. Alternatively, the mutagenized population, or a subsequent generation of that population, can be screened for a mutation in a XylT or FucT gene. For example, the progeny M₂ generation of M₁ plants may be evaluated for the presence of a mutation in a XylT or FucT gene. A “population” is any group of individuals that share a common gene pool. As used herein, “M₀” refers to plant cells (and plants grown therefrom) exposed to a TAL effector nuclease, while “M₁” refers to seeds produced by self-pollinated M₀ plants, and plants grown from such seeds. “M₂” is the progeny (seeds and plants) of self-pollinated M₁ plants, “M₃” is the progeny of self-pollinated M₂ plants, and “M₄” is the progeny of self-pollinated M₃ plants. “M₅” is the progeny of self-pollinated M₄ plants. “M₆”, “M₇”, etc. are each the progeny of self-pollinated plants of the previous generation. The term “selfed” as used herein means self-pollinated.

One or more M₁ tobacco plants can be obtained from individual, mutagenized (M₀) plant cells (and plants grown therefrom), and at least one of the plants can be identified as containing a mutation in a XylT or FucT gene. An M₁ tobacco plant may be heterozygous for a mutant allele at a XylT and/or a FucT locus and, due to the presence of the wild-type allele, exhibit xylosyl- or fucosyltransferase activity. Alternatively, an M₁ tobacco plant may have a mutant allele at a XylT or FucT locus and exhibit the phenotype of lacking xylosyl- or fucosyltransferase activity. Such plants may be heterozygous and lack xylosyl- or fucosyltransferase activity due to phenomena such a dominant negative suppression, despite the presence of the wild-type allele, or may be homozygous due to independently induced mutations in both alleles at the XylT or FucT locus.

A tobacco plant carrying mutant XylT and FucT alleles can be used in a plant breeding program to create novel and useful lines, varieties and hybrids. Thus, in some embodiments, an M₁, M₂, M₃, or later generation tobacco plant containing at least one mutation in a XylT and at least one mutation in a FucT gene is crossed with a second Nicotiana plant, and progeny of the cross are identified in which the XylT and FucT gene mutations are present. It will be appreciated that the second Nicotiana plant can be one of the species and varieties described herein. It will also be appreciated that the second Nicotiana plant can contain the same XylT and FucT mutations as the plant to which it is crossed, different XylT and FucT mutations, or be wild-type at the XylT and/or FucT loci.

Breeding can be carried out via known procedures. DNA fingerprinting, SNP or similar technologies may be used in a marker-assisted selection (MAS) breeding program to transfer or breed mutant XylT and FucT alleles into other tobaccos. For example, a breeder can create segregating populations from hybridizations of a genotype containing a mutant allele with an agronomically desirable genotype. Plants in the F₂ or backcross generations can be screened using markers developed from a XylT and FucT sequences or fragments thereof. Plants identified as possessing the mutant allele can be backcrossed or self-pollinated to create a second population to be screened. Depending on the expected inheritance pattern or the MAS technology used, it may be necessary to self-pollinate the selected plants before each cycle of backcrossing to aid identification of the desired individual plants. Backcrossing or other breeding procedure can be repeated until the desired phenotype of the recurrent parent is recovered.

Successful crosses yield F₁ plants that are fertile and that can be backcrossed with one of the parents if desired. In some embodiments, a plant population in the F₂ generation is screened for XylT and FucT gene expression, e.g., a plant is identified that fails to express XylT and FucT due to the absence of a XylT and FucT genes according to standard methods, for example, using a PCR method with primers based upon the nucleotide sequence information for XylT and FucT described herein. Selected plants are then crossed with one of the parents and the first backcross (BC₁) generation plants are self-pollinated to produce a BC₁F₂ population that is again screened for variant XylT and FucT gene expression (e.g., null versions of the XylT and FucT genes). The process of backcrossing, self-pollination, and screening is repeated, for example, at least 4 times until the final screening produces a plant that is fertile and reasonably similar to the recurrent parent. This plant, if desired, can be self-pollinated, and the progeny subsequently can be screened again to confirm that the plant lacks XylT and FucT gene expression. Cytogenetic analyses of the selected plants optionally can be performed to confirm the chromosome complement and chromosome pairing relationships. Breeder's seed of the selected plant can be produced using standard methods including, for example, field testing, confirmation of the null condition for XylT and FucT, and/or analyses of cured leaf to determine the level of xylosyl- and fucosyltransferase activity.

In situations where the original F₁ hybrid resulting from the cross between a first, mutant tobacco parent and a second, wild-type tobacco parent, is hybridized or backcrossed to the mutant tobacco parent, the progeny of the backcross can be self-pollinated to create a BC₁F₂ generation that is screened for the mutant XylT and FucT alleles.

The result of a plant breeding program using the mutant tobacco plants described herein can be novel and useful lines, hybrids and varieties. As used herein, the term “variety” refers to a population of plants that share constant characteristics which separate them from other plants of the same species. A variety is often, although not always, sold commercially. While possessing one or more distinctive traits, a variety can be further characterized by a very small overall variation between individuals within that variety. A “pure line” variety may be created by several generations of self-pollination and selection, or vegetative propagation from a single parent using tissue or cell culture techniques. A variety can be essentially derived from another line or variety. As defined by the International Convention for the Protection of New Varieties of Plants (Dec. 2, 1961, as revised at Geneva on Nov. 10, 1972, on Oct. 23, 1978, and on Mar. 19, 1991), a variety is “essentially derived” from an initial variety if: a) it is predominantly derived from the initial variety, or from a variety that is predominantly derived from the initial variety, while retaining the expression of the essential characteristics that result from the genotype or combination of genotypes of the initial variety; b) it is clearly distinguishable from the initial variety; and c) except for the differences which result from the act of derivation, it conforms to the initial variety in the expression of the essential characteristics that result from the genotype or combination of genotypes of the initial variety. Essentially derived varieties can be obtained, for example, by the selection of a natural or induced mutant, a somaclonal variant, a variant individual from plants of the initial variety, backcrossing, or transformation. A “line” as distinguished from a variety most often denotes a group of plants used non-commercially, for example in plant research. A line typically displays little overall variation between individuals for one or more traits of interest, although there may be some variation between individuals for other traits.

Hybrid tobacco varieties can be produced by preventing self-pollination of female parent plants (i.e., seed parents) of a first variety, permitting pollen from male parent plants of a second variety to fertilize the female parent plants, and allowing F₁ hybrid seeds to form on the female plants. Self-pollination of female plants can be prevented by emasculating the flowers at an early stage of flower development. Alternatively, pollen formation can be prevented on the female parent plants using a form of male sterility. For example, male sterility can be produced by cytoplasmic male sterility (CMS), or transgenic male sterility wherein a transgene inhibits microsporogenesis and/or pollen formation, or self-incompatibility. Female parent plants containing CMS are particularly useful. In embodiments in which the female parent plants are CMS, pollen is harvested from male fertile plants and applied manually to the stigmas of CMS female parent plants, and the resulting F₁ seed is harvested.

Varieties and lines described herein can be used to form single-cross tobacco F₁ hybrids. In such embodiments, the plants of the parent varieties can be grown as substantially homogeneous adjoining populations to facilitate natural cross-pollination from the male parent plants to the female parent plants. The F₁ seed formed on the female parent plants is selectively harvested by conventional means. One also can grow the two parent plant varieties in bulk and harvest a blend of F₁ hybrid seed formed on the female parent and seed formed upon the male parent as the result of self-pollination. Alternatively, three-way crosses can be carried out wherein a single-cross F₁ hybrid is used as a female parent and is crossed with a different male parent. As another alternative, double-cross hybrids can be created wherein the F₁ progeny of two different single-crosses are themselves crossed. Self-incompatibility can be used to particular advantage to prevent self-pollination of female parents when forming a double-cross hybrid.

This disclosure also provides methods for producing polypeptides (e.g., therapeutic glycoproteins). In some cases, the plants, cells, plant parts, seeds, and progeny provided herein can contain a nucleic acid molecule encoding a heterologous polypeptide. In some cases, the methods provided herein can include providing a Nicotiana plant, plant cell, or plant part having a TAL effector endonuclease-induced mutation in each of a plurality of the endogenous XylT and FucT alleles (i.e., in two or more of the endogenous XylT alleles and in two or more of the endogenous FucT alleles), where the plant, plant cell, or plant part further contains a nucleic acid encoding a heterologous polypeptide. The coding sequence for the heterologous polypeptide can be operably linked to a plant-expressible promoter, and also to a sequence involved in transcription termination and polyadenylation. In some cases, the methods also can include maintaining the plant or plant cell under conditions (e.g., suitable temperature, humidity, light/dark, airflow, and nutritional conditions, in a greenhouse and/or in aqueous conditions) and for a time (e.g., 6 to 12 hours, 12 to 24 hours, 24 to 48 hours, 48 hours to 7 days, 7 days to 30 days, or more than 30 days) sufficient for the polypeptide to be produced. In some cases, the methods for producing a polypeptide can further include isolating the expressed polypeptide from the plant or plant cell. Techniques for isolating such polypeptides can include, for example, conventional techniques such as extraction, precipitation, chromatography, affinity chromatography, and electrophoresis.

A “plant-expressible promoter” is a DNA sequence that is capable of controlling (initiating) transcription in a plant cell. This includes any promoter of plant origin, as well as any promoter of non-plant origin that is capable of directing transcription in a plant cell [e.g., promoters of viral or bacterial origin such as the CaMV35S promoter, T-DNA gene promoters, tissue-specific or organ-specific promoters such as seed-specific promoters, organ specific promoters (e.g., stem-, leaf-, root-, or mesophyll-specific promoters)].

In some cases, a Nicotiana plant, plant cell, plant part, seed, or progeny provided herein can contain a nucleic acid encoding a heterologous polypeptide. A “heterologous polypeptide” is a polypeptide that is not naturally occurring in the plant or plant cells. This is in contrast with homologous polypeptides, which are polypeptides naturally expressed by the plant or plant cells. Heterologous and homologous polypeptides that undergo post-translational N-glycosylation are referred to herein as heterologous or homologous glycoproteins, respectively.

Examples of heterologous polypeptides that can be produced using the plants and methods described herein for administration to humans or animals include, without limitation, cytokines, cytokine receptors, growth factors, growth factor receptors, growth hormones, insulin, pro-insulin, erythropoietin, colony stimulating factors, interleukins, interferons, tumor necrosis factor, tumor necrosis factor receptor, thrombopoietin, thrombin, natriuretic peptides, clotting factors, anti-clotting factors, tissue plasminogen activator, urokinase, follicle stimulating hormone, luteinizing hormone, calcitonin, CD proteins, CTLA proteins, T-cell and B-cell receptor proteins, bone morphogenic proteins, neurotrophic factors, rheumatoid factor, RANTES, albumin, relaxin, macrophage inhibitory protein, viral proteins or antigens, surface membrane proteins, enzymes, regulatory proteins, immunomodulatory proteins, homing receptors, transport proteins, superoxide dismutase, G-protein coupled receptor proteins, neuromodulatory proteins, antigens (e.g., bacterial or viral antigens), and antibodies or fragments thereof. In some cases, the plant-produced polypeptides can be used as vaccines.

“Antibodies” include antibodies of the classes IgD, IgG, IgA, IgM, IgE, as well as recombinant antibodies such as single-chain antibodies, chimeric and humanized antibodies, and multi-specific antibodies. The term “antibody” also refers to fragments and derivatives of all of the foregoing, and may further include any modified or derivatized variants thereof that retain the ability to specifically bind an epitope. Antibodies include monoclonal antibodies, polyclonal antibodies, humanized or chimeric antibodies, camelized antibodies, camelid antibodies, single chain antibodies (scFvs), Fab fragments, F(ab′)₂ fragments, disulfide-linked Fvs (sdFv) fragments, anti-idiotypic antibodies, intra-bodies, synthetic antibodies, and epitope-binding fragments of any of the above. The term “antibody” also refers to fusion proteins that include a region equivalent to the Fc region of an immunoglobulin.

The invention will be further described in the following examples, which do not limit the scope of the invention described in the claims.

EXAMPLES

Example 1

Engineering Sequence-Specific Nucleases to Mutagenize the FucT and XylT Gene Families

To completely inactivate or knock-out the members of the XylT gene family in N. benthamiana, sequence-specific nucleases were designed that target the protein coding region in the vicinity of the start codon. The first 90-bp of the coding sequences are identical between the XylT1 and XylT2 genes (FIG. 1). Four TAL effector endonuclease pairs were designed to target the XylT gene family within the first 90 bp using software that specifically identifies TAL effector endonuclease recognition sites, such as TALE-NT 2.0 (Doyle et al., Nucleic Acids Res 40:W117-122, 2012). The TAL effector endonuclease recognition sites for the XylT genes are underlined in FIG. 1 and are listed in Table 1. TAL effector endonucleases were synthesized using methods similar to those described elsewhere (Cermak et al., Nucleic Acids Res 39:e82, 2011; Reyon et al., Nat Biotechnol 30:460-465, 2012; and Zhang et al., Nat Biotechnol 29:149-153, 2011).

The first 130-bp of the coding sequences for the FucT1 and FucT2 genes are conserved but not identical (FIG. 2). TAL effector endonucleases targeting the FucT gene family were engineered using a similar strategy as described above, but because the FucT gene sequences are more divergent than XylT1 and XylT2, sequence variations are present in all four TAL effector endonuclease target sites (bold type in FIG. 2). The TAL effector endonuclease recognition sites for FucT genes are underlined in FIG. 2 and are listed in Table 1. Target sites 1 and 2 contain nucleotide polymorphisms in the TAL effector endonuclease recognition sites, and so two TAL effector endonuclease pairs were generated for each target region to increase the likelihood that the TAL effector endonucleases would recognize their target. For target sites 3 and 4, sequence variations occur in the spacer regions between the TAL effector endonuclease DNA recognition sites, and thus a single TAL effector endonuclease pair binds to the same target sequence in both genes.

Example 2

FucT and XylT TAL Effector Endonuclease Activity in Yeast

To assess the activity of the TAL effector endonucleases targeting the XylT and FucT genes, activity assays were performed in yeast by methods similar to those described elsewhere (Christian et al., Genetics 186:757-761, 2010). For these assays, a target plasmid was constructed with the TAL effector endonuclease recognition site cloned in a non-functional β-galactosidase reporter gene. The target site was flanked by a direct repeat of β-galactosidase coding sequence such that if the reporter gene was cleaved by the TAL effector endonuclease, recombination would occur between the direct repeats and function would be restored to the β-galactosidase gene. β-galactosidase activity, therefore, served as a measure of TAL effector endonuclease cleavage activity.

In the yeast assay, two of the XylT TAL effector endonuclease pairs (XYL_T03 and XYL_T04) exhibited high cleavage activity under two distinct temperature conditions (i.e., 37° C. and 30° C.). Five of the FucT TAL effector endonuclease pairs (two for target site 1, two for target site 2, and one for target site 4) exhibited high cleavage activities at both 37° C. and 30° C. Cleavage activities were normalized to the benchmark nuclease, I-SceI. Results are summarized in Table 2.

Example 3

Activity of the FucT and XylT TAL Effector Endonucleases at their Endogenous Target Sites in N. benthamiana

TAL effector endonuclease activity at endogenous target sites in N. benthamiana was measured by expressing the TAL effector endonucleases in protoplasts and surveying the TAL effector endonuclease target sites for mutations introduced by NHEJ. Methods for protoplast preparation were performed as described elsewhere (Wright et al., Plant J 44:693-705, 2005). Briefly, seeds were sterilized by washing them successively with 100% ethanol, 50% bleach and then sterile distilled water. The sterilized seeds were planted on MS agarose medium supplemented with iron. Protoplasts were isolated from young expanded leaves using the protocol described by Wright et al. (supra).

TAL effector endonuclease-encoding plasmids together with a YFP-encoding plasmid were introduced into N. benthamiana protoplasts by PEG-mediated transformation as described elsewhere (Yoo et al., Nature Protocols 2:1565-1572, 2007). Twenty-four hours after treatment, transformation efficiency was measured by evaluating an aliquot of the transformed protoplasts using a flow cytometer to monitor YFP fluorescence. The remainder of the transformed protoplasts was harvested, and genomic DNA was prepared by a CTAB-based method. Using the genomic DNA prepared from the protoplasts as a template, an approximately 300-bp fragment encompassing the TAL effector endonuclease recognition site was amplified by PCR. The PCR product was then subjected to 454 gyro-sequencing. Sequencing reads with insertion/deletion (indel) mutations in the spacer region were considered as having been derived from imprecise repair of a cleaved TAL effector endonuclease recognition site by NHEJ. Mutagenesis frequency was calculated as the number of sequencing reads with NHEJ mutations out of the total sequencing reads. The values were then normalized by the transformation efficiency.

The activity of the TAL effector endonuclease pairs, XylT03 and XylT04, against their target genes is summarized in Table 3. Both TAL effector endonuclease pairs induced very high frequencies of NHEJ mutations in both XylT1 and XylT2, ranging from 28.2% to 73.8%. Examples of TAL effector endonuclease-induced mutations in XylT1 and XylT2 are shown in FIG. 3. For the FucT1_T02 and FucT2_T02 TAL effector endonuclease pairs, the recognition site of each TAL effector endonuclease pair was conserved in both the FucT1 and FucT2 genes with the exception of a 1-bp polymorphism in one of the two TAL effector endonucleases comprising each pair. As summarized in Table 3, these TAL effector endonuclease pairs generated high frequencies of NHEJ-induced mutations in both genes, ranging from 24.7% to 46.5%. Examples of TAL effector endonuclease-induced mutations on FucT1 and FucT2 loci are shown in FIG. 4.

Example 4

N. Benthamiana Lines with TAL Effector Endonuclease-Induced Mutations in XylT or FucT

N. benthamiana lines are created with mutations in both copies of the XylT gene or both copies of the FucT gene. Based on the 454 pyro-sequencing data, the TAL effector endonuclease pairs with the highest cleavage activity (XylT_T04 and FucT2_T02), are chosen to mutagenize the XylT and FucT genes. Protoplasts are isolated from sterile leaves, and transformed with plasmids encoding one of the following: (i) TAL effector endonuclease XylT_T04; (ii) TAL effector endonuclease FucT2_T02; or (iii) YFP. Transformation efficiencies are monitored by the delivery of the YFP plasmid, which is visualized using a fluorescent microscope or by flow cytometry as described above.

After transformation, protoplast-derived calli are generated (Van den Elzen et al., Plant Molecular Biology 5:299-302, 1985). Immediately after PEG-mediated transformation, protoplasts are re-suspended in K3G1 media at the cell density of 1×10⁵/ml in a small petri dish, and stored at 25° C. in the dark. At day 4 after transformation, when the majority of the protoplasts are beginning their first cell division, the protoplast culture is diluted four-fold in Media C (Van den Elzen et al., supra). At day 7 and day 10, the protoplast cultures are diluted two-fold in MS media. At day 18 after transformation, calli are identified under the light microscope, and one month after transformation, protoplast-derived calli are visible to the eye.

Calli with mutations in the XylT gene or the FucT gene are identified using a T7EI assay (Mussolino et al., supra). One month after transformation, genomic DNA is isolated from pooled calli. Sequences flanking TAL effector endonuclease recognition sites for FucT1, FucT2, XylT1, and XylT2 are PCR-amplified. In the T7E1 assay, amplification products are denatured and re-annealed. If the re-annealed fragments form a heteroduplex, T7 endonuclease I cuts at the site of mismatch. The digested products are then visualized by gel electrophoresis to quantify mutagenesis activity of the TAL effector endonuclease. Calli with mutations in all four alleles of the two XylT or FucT genes are identified. These individual calli are transferred to shoot-inducing medium. After shoots of a few cm in length emerge, they are cut at the base and transferred to root-inducing medium. Once roots form, they are transferred to soil. Plants with mutations in all four alleles of each pair of FucT or XylT genes are assessed by PCR amplification of the target locus and DNA sequencing. Seeds are collected from the modified plants, and inheritance of the trait is monitored in the progeny to confirm stable, heritable transmission of the modified loci.

Example 5

N. Benthamiana Lines with TAL Effector Endonuclease-Induced Mutations in XylT and FucT

To create N. benthamiana lines with mutations in all alleles of all four XylT and FucT genes, protoplasts are transformed with both TAL effector endonucleases, XylT_T04 and FucT2_T02. As described above, calli are generated and screened for mutations in the eight targets—the four alleles of the two XylT genes and the four alleles of the two FucT2 genes. Screening is performed using, for example, the T7EI assay. Potential candidate calli are confirmed by PCR amplification of the target and DNA sequence analysis of the amplification products. Plants are regenerated from calli with inactivating mutations in all eight genes, and mutant plants are regenerated from these calli. Inheritance of the mutations is monitored in the progeny of the regenerated plants.

Alternatively, N. benthamiana lines with mutations in all four alleles of XylT are crossed with the N. benthamiana lines with mutations in all four alleles of FucT. In subsequent generations, the resulting progeny are screened for those individuals with all eight mutations. Screening is performed using the T7EI assay or by PCR amplification and direct DNA sequencing of the PCR products from individual plants.

Example 6

Mutant N. Benthamiana Lines have Reduced Levels of α1,3-Fucose and β1,2-Xylose on Expressed Polypeptides

The presence of α1,3-fucose and β1,2-xylose on heterologous polypeptides expressed in the mutant N. benthamiana lines is assessed by mass spectrometry (Strasser et al., Plant Biotechnol J 6:392-402, 2008). A heterologous polypeptide, such as a human immunoglobulin (e.g., IgG), is expressed by introducing into the mutant N. benthamiana lines the coding sequence for the polypeptide by agroinfiltration or by electroporation of protoplasts derived from mutant lines. Nine days after agroinfiltration or 48 hours after electroporation, total polypeptides are extracted from mutant plants, and IgG is purified using protein G. The heavy chain of the purified antibody is isolated by cutting the corresponding band from a reduced SDS-PAGE gel. The heavy chain protein in this band is used for glycan analysis by LC-MS as described by Strasser et al. (supra).

TABLE 1
TAL effector endonuclease target sequences
		SEQ		SEQ
		ID	Target sequence	ID
Gene	Target sequence	NO:	2	NO:
Xyl_T01	TGAACAAGAAAAAGCTG	45	TCTTCGCTCTCAACTCA	46
Xyl_T02	TGAAAATTCTTGTTTCT	47	AACTCAATCACTCTCTA	48
Xyl_T03	TTCTTGTTTCTCTCTTC	49	ATCACTCTCTATCTCTA	50
Xyl_T04	TCTCTTCGCTCTCAACT	51	CTCTACTTCTCTTCCCA	52
FucT1_	TGAGATCGGCGTCAAAT	53	AATAAGCAATGGCGCAA	54
T01
FucT2_	TGAGATCGTCGTCAAAT	55	GATAAACAATGGCGCAA	56
T01
FucT1_	TTCAAACGCACCCAATA	57	CTCTGTTCGTTGCCCTA	58
T02
FucT2_	TTCAAACGCACCCGATA	59	CTCTGTTCGTTGCCCTA	58
T02
FucT1_	TCTGTTCGTTGCCCTAG	60	TTTCTTTTCTGGTTCGA	61
T03
FucT2_	TCTGTTCGTTGCCCTAG	60	TTTCTTTTCTGGTTCGA	61
T03
FucT1_	TTGCCTCTGTTCGTTGC	62	TTTCTGGTTCGACTCGA	63
T04
FucT2_	TTGCCTCTGTTCGTTGC	62	TTTCTGGTTCGACTCGA	63
T04

TABLE 2
XylT and FucT TAL effector endonuclease activity in yeast
		SEQ		Activity in
		ID		yeast**
Name	TAL effector endonuclease target*	NO:	Comment	37° C.	30° C.
XylT_	TTCTTGTTTCTCTCTTCGCTCTCAACTCAATCACTCTCTATCTCTA	64	Conserved	0.9	0.7
T03			for both
			XylT-1 and
			XylT-2
XylT_	TCTCTTCGCTCTCAACTCAATCACTCTCTATCTCTACTTCTCTTCCCA	65	Conserved	0.9	0.9
T04			for both
			XylT-1 and
			XylT-2
FucT1_	TGAGATCGGCGTCAAATTCAAACGCACCCACTAAGCAATGGCGCAA	66	Variation	0.8	0.6
T01			in DNA
FucT2_	TGAGATCGTCGTCAAATTCAAACGCACCCGATAAACAATGGCGCAA	67	binding	0.9	0.8
T01			domain
FucT1_	TTCAAACGCACCCAATAAGCAATGGCGCAATTGGTTGCCTCTGTTC	68	Variation	0.9	0.7
T02	GTTGCCCTA		in DNA
FucT2_	TTCAAACGCACCCGATAAACAATGGCGCAATTGGTTGCCTCTGTTC	69	binding	0.9	0.7
T02	GTTGCCCTA		domain
FucT1_	TTGCCTCTGTTCGTTGCCCTAGTGATTATAGCTGAGTTTTCTTTTCTG	70	Conserved	0.6	0.5
T04	GTTCGACTCGA		in binding
FucT2_	TTGCCTCTGTTCGTTGCCCTAGTTGTTATAGCAGAAATTTCTTTTCTG	71	domain,	0.6	0.5
T04	GTTCGACTCGA		variation
			in spacer
*Underlining indicates variations
**Normalized to I-SceI (max = 1.0)

TABLE 3
454 Pyro-Sequencing Data for XylT and FucT TAL effector endonucleases
TAL effector		NHEJ mutagenesis freq.
endonuclease	Location of	with TAL effector	NHEJ mutagenesis freq.	Protoplast transformation
name	target site	endonuclease*	with negative control**	efficiency
XylT_T03	XylT1	34.4% (3169)	0.36%	81%
	XylT2	28.2% (420)	0.06%	81%
XyT_T04	XylT1	73.8% (1615)	0.36%	84%
	XylT2	63.9% (464)	0.06%	84%
FucT1_T02	FucT1	39.2% (27470)	0.79%	87%
	FucT2	24.7% (7259)	0.14%	87%
FucT2_T02	FucT1	46.5% (12295)	0.79%	87%
	FucT2	45.0% (6457)	0.14%	87%
*NHEJ mutagenesis frequency was obtained by normalizing the percentage of 454 reads with NHEJ mutations to the protoplast transformation efficiency. The total number of 454 sequencing reads used for this analysis was indicated in parentheses.
**Negative controls were obtained from protoplasts transformed only by the YFP-coding plasmid.

TABLE 4
Representative XylT and FucT sequences
N. benthamiana XylT1 (GenBank EF562628.1; SEQ ID NO: 72)
gatccagaaaagcactgaacgttgtttaaccctctgtagtctactctgtactaagtagtacacacgaaaacagccagt
cggagagagaagaagatgaacaagaaaaagctgaaaattcttgtttctctcttcgctctcaactcaatcactctctat
ctctacttctcttcccaccctgatcacaaatccccccaaaaccacttttccttgtcggaaaaccaccatcataatttc
cactcttcaatcacttctcaatattccaagccttggcctattttgccctcctacctcccttggtctcaaaaccctaat
gttgcttggagatcgtgcgagggttacttcggtaatgggtttactctcaaagttgaccttctcaaaacttcgccggag
tttcaccggaaattcggcgataacaccgtctccggtgacggcggatggtttaggtgttttttcagtgagactttgcag
agttcgatctgcgagggaggcgcaatacgaatgaatccggacgatattttgatgtctcgtggaggtgagaaattggag
tcggttattggtaggaatgaagatgatgagctgcccatgttcaaaaatggagctttccaaattgaagttactgataaa
ctgaaaattgggaaaaaactagtggataaaaaattcttgaataaatacttaccgggaggtgcgatttcaaggcacact
atgcgtgagttaattgactctattcagttggttggcgccgatgaatttcactgttctgagtgggttgaggagccgtca
cttttgattacacgatttgagtatgcaaaccttttccacacagttaccgattggtatagtgcatacgcggcatccagg
gttactggtttgcccagtcggccaaatttggtttttgtagatggccattgtgagacacaattggaggaaacatggaaa
gcacttttttcaagcctcacttatgctaagaactttagtggcccagtttgtttccgtcatgctgtcctctcgccttta
ggatatgaaactgccctgtttaagggactgtcagaaactatagattgtaatggagcttctgctcatgatttgtggcaa
aagcctgatgataaaaaaactgcacggttgtccgagtttggggagatgatcagggcagcctttggatttcctgtggat
agacagaacatcccaaggacagtcacaggccctaatgtcctctttgttagacgtgaggattatttagctcacccacgt
catggtggaaaggtacagtctaggcttagcaatgaagagctagtatttgattccataaagagctgggccttgaaccac
tcggagtgtaaattaaatgtaattaacggattgtttgcccacatgtccatgaaagagcaagttcgagcaatccaagat
gcttctgtcattgttggtgctcatggagcaggtctaactcacatagtttctgcagcaccaaaagctgtaatactagaa
attataagcagcgaatataggcgcccccattttgctctgattgcacaatggaaaggattggagtaccatcccatatat
ttggaggggtcttatgcggatcctccagttgtgatcgacaagctcagcagcattttgaggagtcttgggtgctaaatc
tgctcgacagtttagttcggcttttctctaaaagattgggaaggatagaggaattcggggttctggaacttggagcct
gggaattgtgtaaaatatgtttcacacgcagttctatagtcaattgctgcaatctggtgttcataagcttggaaattt
ccagcagctactaacttattagcccactctgactcagttatggactaccagagagcaattcacaagtaacacgtgtat
gtgaaagcttccatt
N. benthamiana XylT2 (GenBank EF562629.1; SEQ ID NO: 73)
agtacagacgaaaacagcccgtgagagagagagagagaggagaagaagatgaacaagaaaaagctgaaaattcttgtt
tctctcttcgctctcaactcaatcactctctatctctacttctcttcccaccctgatcactctcgtcgcaaatccccc
cagaaccacttttcctcgtcggaaaaccaccatcataatttccactcttcaatcacttcccaatattccaggccttgg
cctattttgccctcctacctcccttggtctcaaaaccctaatgttgcttggagatcatgcgagggttacttcggtaat
ggttttactctcaaagttgatcttctcaaaacttcgccggagcttcaccggaaattcggcgaaaacaccgtcttcgga
gacggcggatggtttaggtgtttcttcagtgagactttgcagagttcgatctgcgagggaggcgcaatacgaatgaat
ccagacgagattttgatgtctcgtggaggtgagaaattggagtcggttattggtaggagtgaagatgatgaggtgccc
gcgttcaaaactggagcttttcagattaaagttactgataaactgaaatttgggaaaaaattagtggatgaaaacttc
ttgaataaatacttaccggaaggtgcaatttcaaggcacactatgcgtgagttaatcgactctattcagttggttggc
gccaatgattttcactgttctgagtggattgaggagccgtcacttttgattacacgatttgagtatgcaaaccttttc
cacacaattaccgattggtatagtgcatacgtggcatcgagggttactggcttgcccagtcggccacatttggttttt
gtagatggccattgtgagacacaattggaggaaacatggaaagcacttttttcaagcctcacttatgctaagaacttt
agtggcccagtttgtttccgtcatgccgtcctctcgcctttgggatatgaaactgccctgtttaagggactgtcagaa
actatagattgtaatggagcttctgctcatgatttgtggcaaaatcctgatgataagaaaactgcacggttatccgag
tttggggagatgatcagggcagcctttggatttcctgttgatagacagaacatcccaaggacagtcacaggccctaat
gtcctctttgttagacgtgaggattatttagctcacccacgtcatggtggaaaggtacagtctaggcttagcaatgaa
gagcaagtatttgattccataaagagctgggccttaaaccactcggagtgcaaattaaatgtaattagtggattgttt
gcccacatgtccatgaaagagcaagttcgagcaatccaagatgcttctgtcattgttggtgctcatggagcaggtcta
acccacatagtttctgcagcaccaaaagctgtaatactagaaattataagcagcgaatataggcgcccccattttgct
ctgattgctcaatggaaaggattggagtaccatcccatatatttggaggggtcttatgcggatcctccagttgtgatc
gacaagctcagcagcattttgaggagtcttgggtgctaaatctgctcgacagtttgaatagattagtttttgtctaaa
agactgggaaggaaaaagaggagtttggggttctgcaacatggagcatgagaattgtgtaaaatatgtttcacacgca
gttctatagtcaattgctgcaatctggtgtttataagcttggaaatttccagcagctactaacttattagcccactct
gactcagttatggactaccagagcaatcatatcaaatgggagcatggaatcctgattgtggaattgtgatctcattga
agagcatattctttaaggtgttgaagattacagttgaccagtaacacgtgtatgtgaaagattaggttgttacacttt
cttgcaattcattgtcaatttttttattaatggtcataggataagaacatgagaaaaccatccatgttctgtgttgtt
ttcccatcaatctggccaccctctttcctccttatgttgagatg
N. tabacum XylT (GenBank DQ192540.1; SEQ ID NO: 74)
gtcagagagagaagaagatgaacaagaaaaagctgaaatttcttgtttctctcttcgctctcaactcaatcactctct
atctctacttctcttcccactctgatcacttccgtcacaaatccccccaaaaccactttcctaatacccaaaaccact
attccctgtcggaaaaccaccatgataatttccactcttctgtcacttcccaatataccaagccttggccaattttgc
cctcctacctcccctggtctcagaatcctaatgtttctttgagatcgtgcgagggttacttcggtaatgggtttactc
tcaaagttgatcttctcaaaacttcgccggagcttcaccagaaattcggcgaaaacaccgtatccggcgacggcggat
ggtttaggtgttttttcagtgagactttgcagagttcgatttgcgagggaggtgctatacgaatgaatccggacgaga
ttttgatgtctcgtggaggcgagaaattggagtcggttattggtaggagtgaagatgatgagctgcccgtgttcaaaa
atggagcttttcagattaaagttactgataaactgaaaattgggaaaaaattagtggatgaaaaaatcttgaataaat
acttaccggaaggtgcaatttcaaggcacactatgcgtgaattaattgactctattcagttagttggcgccgatgaat
ttcactgttctgagtggattgaggagccgtcacttttgattacacgatttgagtatgcaaaccttttccacacagtta
ccgattggtatagtgcatacgtggcatccagggttactggcttgcccagtcggccacatttggtttttgtagatggcc
attgtgagacacaattggaggaaacatggaaagcactcttttcaagcctcacttatgctaagaactttagtggcccag
tttgtttccgtcacgccgttctctcgcctttgggatatgaaactgccctgtttaagggactgacagaaactatagatt
gtaatggagcttctgcccatgatttgtggcaaaatcctgatgataagagaactgcacggttgtccgagtttggggaga
tgatcagggcagcctttggatttcctgtggatagacagaacatcccaaggacagtcacaggccctaatgtcctctttg
ttagacgtgaggattatttagctcacccacgtcatggtggaaaggtacagtctaggcttagcaatgaagagcaagtat
ttgattccataaagagctgggccttgaaccactcggagtgcaaattaaatgtaattaacggattgtttgcccacatgt
ccatgaaagagcaagttcgagcaatccaagatgcttctgtcatagttggtgctcatggagcaggtctaactcacatag
tttctgcagcaccaaaagctgtaatactagaaattataagcagcgaatataggcgcccccattttgctctaattgcac
aatggaaaggattggagtaccatcccatatatttggaggggtcttatgcggatcctccagttgtgatcgacaagctca
gcagcattttgaggagtcttgggtgctaaatctgctcgacagtttagttcgtcttttctctaaaagactgggaaggat
agaggaattcggggttctggaacctggagcctgggaattgtgtaaaatatgtttcacacgcagttctatagtcaattg
ctgcaatctggtgttcataagcttggaaatttccagcagctactaacttattagcccactctgactcagttatggact
accagagcaatcatatcaaatgggagcatggaatcctgattgtggaatggtgagctcattgaagagcatattctttat
ggtgttgaagattacagttgacgagtaacacgtgtatgtgaaagattaggttgttacactttcttgcaattcattgtc
aattgtttttcgtcattcttattaatgatcataggataagaacatgagaaaaccatccatgttctctgttgttttccc
atcaatctggccaccctctttcctctttatgtagagatgatttcaacagagtttgttttgtagttgtaatacttgtac
tcacagttactgttttgcattcatcccatcagatgtcgaagaagcagattaacaagaacgtcagtatgatgtttcagt
gaatatatggttgtaacttgtaaccaaacaaaagaaatgagactttgaccaaagattttgtcacaaaaaaaaaaaa
N. tabacum putative XylT (GenBank AJ627182; SEQ ID NO: 75)
agtcagagagagaagaagatgaacaagaaaaagctgaaatttcttgtttctctcttcgctctcaactcaatcactctc
tatctctacttctcttcccactctgatcacttccgtcacaaatccccccaaaaccactttcctaatacccaaaaccac
tattccctgtcggaaaaccaccatgataatttccactcttctgtcacttcccaatataccaagccttggccaattttg
ccctcctacctcccctggtctcagaatcctaatgtttctttgagatcgtgcgagggttacttcggtaatgggtttact
ctcaaagttgatcttctcaaaacttcgccggagcttcaccagaaattcggcgaaaacaccgtatccggcgacggcgga
tggtttaggtgttttttcagtgagactttgcagagttcgatttgcgagggaggtgctatacgaatgaatccggacgag
attttgatgtctcgtggaggcgagaaattggagtcggttattggtaggagtgaagatgatgagctgcccgtgttcaaa
aatggagcttttcagattaaagttactgataaactgaaaattgggaaaaaattagtggatgaaaaaatcttgaataaa
tacttaccggaaggtgcaatttcaaggcacactatgcgtgaattaattgactctattcagttagttggcgccgatgaa
tttcactgttctgagtggattgaggagccgtcacttttgattacacgatttgagtatgcaaaccttttccacacagtt
accgattggtatagtgcatacgtggcatccagggttactggcttgcccagtcggccacatttggtttttgtagatggc
cattgtgagacacaattggaggaaacatggaaagcactcttttcaagcctcacttatgctaagaactttagtggccca
gtttgtttccgtcacgccgttctctcgcctttgggatatgaaactgccctgtttaagggactgacagaaactatagat
tgtaatggagcttctgcccatgatttgtggcaaaatcctgatgataagagaactgcacggttgtctgagtttggggag
atgatcagggcagcctttggatttcctgtggatagacagaacatcccaaggacagtcacaggccctaatgtcctcttt
gttagacgtgaggattatttagctcacccacgtcatggtggaaaggtacagtctaggcttagcaatgaagagcaagta
tttgattccataaagagctgggccttgaaccactcggagtgcaaattaaatgtaattaacggattgtttgcccacatg
tccatgaaagagcaagttcgagcaatccaagatgcttctgtcatagttggtgctcatggagcaggtctaactcacata
gtttctgcagcaccaaaagctgtaatactagaaattataagcagcgaatataggcgcccccattttgctctgattgca
caatggaaaggattggagtaccatcccatatatttggaggggtcttatgcggatcctccagttgtgatcgacaggctc
agcagcattttgaggagtcttgggtgctaagtccgctcgacagtttgaatagttcggcttttctctaaaagacgggga
aggatagaggaattcggggttctggaacttggagcctgggaattttgataaatatgtttcacacgcagttctgtagtc
aatggttgcaatctaggtcctcaatctggtgttgataagcttggcaatttccagcagctactaatttattagcccgct
ctgactcggttatggactaccagagcaatcatatcaaatggaagcatggaatcctgattgtggaatggtgagctcatt
gaagagcatattctttatggtgttgaagattacaattcacaattaacacgtgtatgtgaaagattaggttggtacact
tacttacaattcattgtcaattgtttttcattattctcattaatgatcataggataagaacatgagaaaaccatccat
gttctgtgttgttttcccatcaatccggccaccctcttccctccttatgtagagatgatttcaacagagtttgttttg
tagttgtaacacttgcactcccagttacagttttgcattcgacacattcatcccatcagatgtcaagtttaaaggcat
aagacatttgacatattgaagaagcagattaacacgaacgtcagtatgatgcttcagtgaagatatggttgtaacttg
taaccaaacaaaagaaatgagactttgacaaaaaaaaaaaaaaaaaaaaaaaaaaa
N. benthamiana FucT1 (GenBank EF562630.1; SEQ ID NO: 76)
atgagatcggcgtcaaattcaaacgcacccaataagcaatggcgcaattggttgcctctgttcgttgccctagtgatt
atagctgagttttcttttctggttcgactcgacgtagctgaaaaagccaactcttgggccgaatcgttttatcagttc
accacggcctcttggtccacctctaaactggctgttgaccacggcgacgttgaggaggtccagttgggtgttttgagt
ggtgagttcgatcatggcttcgtacctgggagttgcgaggagtggttggaaagggaagattctgtggcttattcgagg
gattttgataatgaaccaatttttgttcatgggcctggacaggaattgaaatcttgttccataggatgtaagtttgga
acagattccaataagaagcctgatgcagcatttcggctaccacaacaagctggcacagctagtgtgctacggtcgatg
gagtcagctcaatactatgcagagaacaacattactttggcacgacgaaggggatatgatgttgtaatgacaacaagc
ctctcttcagatgttcctgttggatacttctcttgggctgagtatgatatcatggctccagtagaacctaaaacagag
aatgccttggcagcggctttcatttctaattgtggtgctcgcaacttccgtttgcaagctttagaagcccttgaaagg
gcaaatatcagaattgactcttatggaagttgtcatcataacagggatggaagagttgacaaagtggcagcactgaag
cgttaccagtttagcttggcttttgagaattctaatgaggaggactatgtaactgaaaaattctttcagtctctggta
gctgggtcaatccctgtggtggttggtgctccaaacatccaagactttgcgccttctcctaattcagttttacacatt
aaagagataaaagatgctgaatcaattgccaataccatgaagtaccttgctcaaaaccctattgcatataatgagtca
ttaaggtggaagtttgagggcccatctgatgccttcaaagcccttgttgatatggcagcagttcattcatcttgtcgt
ttgtgcatcttcttggcaagtaggatccgggaaagagaagagcagagtccaaaatttatgaagcgtccctgcaaatgt
accagagggactgaaactgtatatcatgtatatgtaggtgaaagaggcaggtttgagatggattccattttcttaagg
tcgagtgatttgtctttgaaggcgtttgaatctgctatcctctcgaggttcaagtctgttaaacatgttcctgtttgg
aaggaggaaagacctcaagtactacgaggtggtgatgaactcaaactttacaaagtatatcctgttggcttgacacag
agacaagcattgttttccttcagattcaacggggatactgagtttaacaattacattcaaagccacccatgtgcaaaa
tttgaagccatcttcgtatag
N. benthamiana FucT (pseudogene, GenBank EF562631.1; SEQ ID NO: 77)
atgagatcgtcgtcaaattcaaacgcacccgataaacaatggcgcaattggttgcctctgttcgttgccctagttgtt
atagcagaaatttcttttctggttcgactcgacgtggctgaaaaagccaactcttgggctgagtcgttttatcagttc
accacggcgtcttggtcaacctccaaactggctgttgacggcggcgatgttgatgaggtcctgttgggtgttttgagt
ggtgagtttgatcagggcttcctaccttggagttgcgaggagtggttggaaagggaagattatgtggcttattcgagg
gattttgataatgaaccaatttttgttcatgggcctggacaggaattgaaatcttgttccataggatgtaagtttgga
acagattccaataagaagcctgatgcagcatttcggctaccacaacaagctggcacagctagtgtgctacggtcgatg
gagtcagctcaatactatgcagagaacaacattactttggcacgacgaaggggatatgatgttgtaatgacaacaagc
ctctcttcagatgttcctgttggatacttctcttgggctgagtatgatatcatggctccagtagaacctaaaacagag
aatgccttggcagcggctttcatttctaattgtggtgctcgcaacttccgtttgcaagctttagaagcccttgaaagg
gcaaatatcagaattgactcttatggaagttgtcatcataacagggatggaagagtagacaaagtggcagcactgaag
cgttacaagtttagcttggcttttgagaattctaatgaggaggactatgtaaccgaaaaattctttcagtctctggta
gctgggtcaatccctgtggtggttggtgctccaaacatccaagactttgcgccttctcctaattcagttttacacatt
aaagagataaaagatgctgaattaattgccaataccatgacgtaccttgctcaaaaccctattgcatctaatgagtca
ttaaggtggaagtttgagggcccatttgatgccttcaaagccctggttgatatggcagcagttcattcatcttgccgt
ttgtgcatcttcttggcaagtaggatccaggaaagagaagagcatagtccaaaatttacgaagcgcccctgcaaatgt
accagagagactgaaactgtctatcatgtatatgtacgtgaaagagggaggtttgagatggattccattttcttaagg
tcgagtgatttgtctttaaaggcgtttgaatctgctattctctcgaggttcaagtctgttaaacatgttcctgtttgg
agggaggaaagacctcaagtactacgaggtggtgatgaactcaaactttactaagtatatcctgttggcttgacacag
agacaagcattgttttccttcagattcaacggggatactgagtttaagaattacattcaaagccacccatgtgcaaaa
tttgaagccatcttcgtatag
N. tabacum FucT (GenBank AB498916.1; SEQ ID NO: 78)
aacccccccccccccccacccccaactgtcccaccaaatgaagaattcccaaaccctctgaagaagaagaaaaaaaga
tcacatctttagctattttacttccacaaaaagaacaaaatttcgagttattaatggcaacagttattccaattcaaa
ggttaccaagatttgaaggtgttgggtcatcatcacctacaaacgttccccttaagaaatggtccaattggctacctc
tagtagttgcacttgtggttatagttgaaattacatttctgggtcgactggacatggctgaaaaagccaacctggtca
actcttggactgactcattttaccagtttacgacgtcgtcttggtcaacctccaaagtggaaattagtgagactgggt
tgggtgtgttgaggagtagtgaggttgatcggaatttggaaactgggagctgtgaggagtggttggaaaaggaggatt
ctgtggagtattctagagattttgacaaagacccaatttttgttcatggcggcgaaaaggattggaagtcttgtgccg
taggatgtaactttggtgtggattctgaaaagaagcctgatgcggcatttgggacaccacaacaggctggcacggcta
gcgtgcttcggtcaatggagtcagctcaatactatcctgagaacaacatcgttatggcacgacgaaggggatatgata
ttgtaatgacaacaagcctctcttcggatgttcctgttgggtacttctcttgggcggagtatgatataatggctccag
tgcaacctaaaactgagaatgcgttagcagctgcttttatttctaattgtggtgctcgcaacttccggttacaggctc
ttgaagtccttgaaagggcaaatatcaagattgattcttttggcagttgtcatcgtaaccgggatggaaatgtggaca
aagtggaaactctcaagcgctataaatttagcttcgcttttgagaattctaatgaggaggattatgtcaccgaaaaat
tcttccagtctctggtagctggatcagtccctgtggtgattggtgctccaaacatcctagactttgctccttctccta
attcacttttacacattaaagagctgaaagacgctgcatcagttgccgagactatgaagtaccttgcagaaaatccta
gtgcatataatgagtcattaaggtggaagcttgacggtccatctgactctttcaaagccctggttgacatggcagcag
ttcactcttcttgtcgtttgtgtatcttcttagcaactagtattagggagaaagaagagaagagtccagaatttacaa
aacgtccctgcaaatgtaccagaggttcagaaactgtctatcatatatatgtacgtgaaagagggaggtttgacatgg
agtccattttcctaaggtcatctaatttgtcattggaggcttttgaatctgcagtactgtcgaagttcaaatctttaa
agcatgttcccatttggaaagaagaaagacctcaaatactacgcggaggggatgaactaaagctctacagggtatatc
ctctcggcatgacacaacgacaggcattgtacacctccagattcaaaggagacgccgattttaggaatcacatcgaaa
gccacccatgtgcaaattttgaagccatatttgtatagatcaagtccaaacctgagagtctcgacagcagcttgttgt
aggccatagcgtaatgctcattcttactctatgccccactgtctaacatcattctggttatgaattcgtcgtgtagag
taaggatttgattattacatggggccaacctaattttgggtggaaagtactgatcttttacatttacaagtaagaagg
aacaaactctgaaccttgaatggacatgcctaacctcccaaagttgtgcagttgggaaattgcgggtgatatacaaac
ttggacttggttttgctagcagaaaattctagctgatcaatttgtaatctagttcagaggacatctccatcgtgttac
aagtaatgacaagtgcagaaactaattaaaggttcttttcggaaaaaaaaaaaaaa

Other Embodiments

It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.

Claims

1. A Nicotiana plant or plant cell comprising a mutation in each of a plurality of XylT alleles and a mutation in each of a plurality of FucT alleles, wherein said plant or plant cell does not produce detectable levels of beta-1,2-xylosyl- or core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in said plant or plant cell.

2. The plant or plant cell of claim 1, wherein said mutations are at one or more sequences as set forth in SEQ ID NOS:1, 2, or 3.

3. The plant or plant cell of claim 1, wherein said mutations were induced by one or more rare-cutting endonucleases.

4. The plant or plant cell of claim 3, wherein said one or more rare-cutting endonucleases are transcription activator-like (TAL) effector endonucleases.

5. The plant or plant cell of claim 4, wherein each of said TAL effector endonucleases binds to a sequence as set forth in any of SEQ ID NOS:45-63.

6. The plant or plant cell of claim 1, wherein said plant or plant cell comprises a nucleic acid encoding a heterologous polypeptide.

7. The plant or plant cell of claim 1, wherein each of said mutations is a deletion of more than one nucleotide.

8. The plant or plant cell of claim 1, wherein each of said plurality of XylT alleles and said plurality of FucT alleles has a deletion of an endogenous nucleic acid sequence and does not include any exogenous nucleic acid.

9. The plant or plant cell of claim 1, wherein said plant or plant cell is a N. benthamiana plant or plant cell.

10. A method for producing a polypeptide, comprising:

(a) providing a Nicotiana plant or plant cell comprising a mutation in each of a plurality of XylT alleles and a mutation in each of a plurality of FucT alleles, wherein said plant or plant cell does not produce detectable levels of beta-1,2-xylosyl- and core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in said plant or plant cell, and wherein said plant or plant cell comprises a nucleic acid comprising (i) a nucleotide sequence encoding a polypeptide operably linked to (ii) a plant-expressible promoter and (iii) a sequence involved in transcription termination and polyadenylation, wherein said polypeptide is heterologous to said plant; and

(b) growing said plant or plant cell under conditions and for a time sufficient that said heterologous polypeptide is produced.

11. The method of claim 10, further comprising isolating said heterologous polypeptide from said plant or plant cell.

12. The method of claim 10, wherein said mutations were induced by one or more rare-cutting endonucleases.

13. The method of claim 12, wherein said one or more rare-cutting endonucleases are TAL effector endonucleases.

14. The method of claim 13, wherein each of said TAL effector endonucleases binds to a sequence as set forth in any of SEQ ID NOS:45-63.

15. A method for making a Nicotiana plant that comprises a mutation in each of a plurality of XylT alleles and a mutation in each of a plurality of FucT alleles, said method comprising:

(a) contacting a population of Nicotiana plant cells comprising functional XylT alleles and functional FucT alleles with one or more rare-cutting endonucleases targeted to endogenous XylT sequences, and one or more rare-cutting endonucleases targeted to endogenous FucT sequences,

(b) selecting, from said population, a cell in which a plurality of XylT alleles and a plurality of FucT alleles have been inactivated, and

(c) regenerating said selected plant cell into a Nicotiana plant, wherein said Nicotiana plant comprises mutations in a plurality of XylT alleles and mutations in a plurality of FucT alleles, and does not produce detectable levels of beta-1,2-xylosyl- or core alpha-1,3-fucosyl-sugars on N-glycan structures of glycoproteins produced in said plant.

16. The method of claim 15, wherein said Nicotiana plant cells are protoplasts.

17. The method of claim 16, comprising transforming said protoplasts with one or more vectors comprising encoding a rare-cutting endonuclease.

18. The method of claim 17, wherein said one or more rare-cutting endonucleases are TAL effector endonucleases.

19. The method of claim 18, wherein each of said TAL effector endonucleases is targeted to a sequence as set forth in any of SEQ ID NOS:45-63.

20. The method of claim 15, comprising introducing into said protoplasts a TAL effector endonuclease protein.